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As of May 25, 2020, there were reported 
5,432,512 confirmed COVID-19 cases, with the mortality 
rate of nearly 6.9%. So far, no data have been available 
on the survival of patients with COVID-19 after cardiac 
arrest. Currently, a study by Shao et al.1 is the only one 
to present the outcomes of in-hospital cardiac arrest 
(IHCA) among patients with COVID-19 pneumonia. 
Shao et al. indicate that the return of spontaneous cir-
culation after IHCA is observed in 13.6% of patients with 
severe COVID-19 pneumonia, and the 30-day survival 
is even worse and equals 2.9%. Owing to the progres-
sive virus pneumonia in these patients, they should 
be monitored and treated in ICUs, as this increases 
their statistical survival compared with general wards 
(RR = 14.74; 95% CI: 1.6–135.48; p = 0.02).
The prevailing pandemic forces us, as medical 
professionals, to accept compromises, which often 
includes making difficult choices about whom to save. 
Hence, the question arises whether we should resus-
citate all patients with COVID-19. The answer may 
contradict the general principle of “first do not harm” 
and pose ethical dilemmas. We must remember that in 
addition to the safety of a given patient, we must also 
take into account our safety, as well as that of other 
patients. A COVID-19 patient resuscitation increases 
the risk of infection among medical personnel and 
subsequent transmission of the virus to other patients 
or family members. Moreover, in times of resource 
insufficiency, medical personnel contamination and 
the consequent quarantine further reduce the potential 
of hospitals. Shao et al. [1] revealed that the highest 
30-day survival rate was observed in patients with
VF/pVT rather than PEA or asystole as the initial rhythm 
(RR = 48.00; 95% CI: 4.61–411.04; p < 0.001).
Another dilemma associated with the resuscitation pro-
cess is that, according to the Centers for Disease Control 
and Prevention, each aerosolizing procedure should be 
performed with personal protective equipment, consisting 
of N95 respirators, eye protection, gloves, and gowns; 
the procedures themselves should be implemented in 
airborne infection isolation rooms [2]. In severe SARS-
CoV-2 pneumonia, the main cause of cardiac arrest is re-
spiratory failure and the most frequently observed rhythm is 
asystole resulting from hypoxia. Intubation and ventilation 
of COVID-19 patients have poor survival rates [3].
In summary, in order to reduce the risk of infection, 
we should consider not resuscitating COVID-19 patients 
with observed non-shockable rhythms, especially those 
over 60 years of age.
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